ORIGINAL RESEARCH article

Front. Oncol., 21 December 2020

Sec. Pharmacology of Anti-Cancer Drugs

Volume 10 - 2020 | https://doi.org/10.3389/fonc.2020.595718

RETRACTED: Disulfiram Chelated With Copper Inhibits the Growth of Gastric Cancer Cells by Modulating Stress Response and Wnt/β-catenin Signaling

Retracted

A retraction of this article was approved in:

  1. Retraction: Disulfiram Chelated With Copper Inhibits the Growth of Gastric Cancer Cells by Modulating Stress Response and Wnt/β-catenin Signaling Author: Frontiers Editorial Office*

    1. Read retraction
Ling WangLing Wang1Xiaoke ChaiXiaoke Chai1Run WanRun Wan1Hong ZhangHong Zhang2Cong ZhouCong Zhou1Lin XiangLin Xiang3Maswikiti Ewetse PaulMaswikiti Ewetse Paul1Yumin Li*Yumin Li1*
  • 1Key Laboratory of Digestive System Tumors of Gansu Province, Lanzhou University Second Hospital, Lanzhou, China
  • 2Department of Pathology, First Hospital of Lanzhou University, Lanzhou, China
  • 3Department of Pathology, Lanzhou University Second Hospital, Lanzhou, China

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Wang L, Chai X, Wan R, Zhang H, Zhou C, Xiang L, Paul ME and Li Y (2020) Disulfiram Chelated With Copper Inhibits the Growth of Gastric Cancer Cells by Modulating Stress Response and Wnt/β-catenin Signaling. Front. Oncol. 10:595718. doi: 10.3389/fonc.2020.595718

Received: 17 August 2020; Accepted: 09 November 2020;
Published: 21 December 2020; Retracted: 27 August 2024.

Edited by:

Ahmed Mohamed Al-Abd, Gulf Medical University, United Arab Emirates

Reviewed by:

Rania Zaarour, Gulf Medical University, United Arab Emirates
Rasha Allam, National Research Centre, Egypt

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Research integrity at Frontiers

94% of researchers rate our articles as excellent or good

Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


Find out more